MENU
FGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
FibroGen (FGEN) Ownership - Who owns FibroGen?
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
409 Illinois Street
Phone
+1 415 978-1200
Employees
486
Web
https://www.fibrogen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
45.01M
P/E Ratio
N/A
Total Cash
23.37M
Projected Growth
N/A
Total Debt
73.73M
Revenue
7.35M
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash/Share
5.78
Total Debt/Equity
N/A
Revenue/Share
1.82 USD as % of share price
Fundamentals
FGEN
Capitalization
45M
P/E Ratio
N/A
Risk (Beta)
1.18
Dividend Yield
N/A
Total Cash
23.4M
Total Cash/Share
5.78
Total Debt
73.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.82%
Revenue
7.35M
ROE
N/A
Book Value
-223M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.01M
Current Ratio
1.04
Current Revenue Per Employee
5991.11
Dividends Per Share - Security
N/A
EBITDA
-77.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.69
Revenue To Assets
-0.88
Shares Held By Institutions
10M
Shares Outstanding - Current
4.04M
Total Liabilities
359M
Total Volume MTD
N/A
Value
-1
Gain YTD
-15.921
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
a developer of biotechnology-based drugs
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
409 Illinois Street
Phone
+1 415 978-1200
Employees
486
Web
https://www.fibrogen.com